1. Home
  2. VACH
  3. VACH News

Latest VOYAGER ACQUISITION CORP. (VACH) News on July 18, 2025

Ulta Stock Jumps as Beauty Product Spending Continues
VACH

Investopedia

2 months ago

Ulta Stock Jumps as Beauty Product Spending Continues

Drone Light Show Market to Soar to $5 Billion by 2034, Fueled by 13% CAGR and Rising Demand for Innovative Entertainment | Exactitude Consultancy
VACH

GlobeNewswire

2 months ago

Drone Light Show Market to Soar to $5 Billion by 2034, Fueled by 13% CAGR and Rising Demand for Innovative Entertainment | Exactitude Consultancy

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy
VACH

GlobeNewswire

2 months ago

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy

Northrop Grumman Raises $1 Billion Via Debt
VACH

Benzinga

2 months ago

Northrop Grumman Raises $1 Billion Via Debt

Spinosad Active Ingredient Market Set for Steady Growth, Driven by Sustainable Farming Trends | Exactitude Consultancy
VACH

GlobeNewswire

2 months ago

Spinosad Active Ingredient Market Set for Steady Growth, Driven by Sustainable Farming Trends | Exactitude Consultancy

The York Water Company Files a Rate Request Based on $145 Million in Investment
VACH

GlobeNewswire

2 months ago

The York Water Company Files a Rate Request Based on $145 Million in Investment

VACH

Newsfile

2 months ago

Max Resource Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

TEN, Ltd. Announces Date for the First Quarter 2025 Results, Conference Call and Webcast
VACH

GlobeNewswire

2 months ago

TEN, Ltd. Announces Date for the First Quarter 2025 Results, Conference Call and Webcast

VACH

GlobeNewswire

2 months ago

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
VACH

GlobeNewswire

2 months ago

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

VACH

MT Newswires

2 months ago

OmniAb, Veraxa Biotech Partner on Solid Tumor Drug Discovery Program

VACH

GlobeNewswire

2 months ago

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

Veraxa to go public in $1.6bn SPAC deal with Voyager
VACH

Pharmaceutical Technology

3 months ago

Veraxa to go public in $1.6bn SPAC deal with Voyager

VACH

MT Newswires

3 months ago

Voyager Acquisition, VERAXA Biotech to Merge, Creating $1.64 Billion Public Cancer Therapy Company

VACH

GlobeNewswire

3 months ago

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

Share on Social Networks: